Voyager Therapeutics, Inc. VYGR Q3 2025 earnings

FAQ

When did Voyager Therapeutics, Inc. report Q3 2025 earnings?

Voyager Therapeutics, Inc. (VYGR) reported Q3 2025 earnings on November 10, 2025 before market open.

What were Voyager Therapeutics, Inc.'s Q3 2025 revenue and EPS?

Voyager Therapeutics, Inc. reported revenue of $13.4M and eps of $-0.47 for Q3 2025.

Did Voyager Therapeutics, Inc. beat estimates in Q3 2025?

Revenue beat the consensus estimate of $10.5M by $2.9M. EPS beat the consensus estimate of $-0.53 by $0.06.

How did Voyager Therapeutics, Inc.'s Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 45.7% from $24.6M a year earlier and eps declined 193.7% from $-0.16.

Where can I find Voyager Therapeutics, Inc.'s Q3 2025 SEC filings?

You can read the 8-K earnings release (0001104659-25-108841) and the 10-Q periodic report (0001104659-25-108846) directly on SEC EDGAR. The filing index links above go to sec.gov.